IT961352B - Resine di inclusione e procedi mento per la loro preparazione - Google Patents

Resine di inclusione e procedi mento per la loro preparazione

Info

Publication number
IT961352B
IT961352B IT7649/65A IT764965A IT961352B IT 961352 B IT961352 B IT 961352B IT 7649/65 A IT7649/65 A IT 7649/65A IT 764965 A IT764965 A IT 764965A IT 961352 B IT961352 B IT 961352B
Authority
IT
Italy
Prior art keywords
resin
cyclodextrin
inclusion
cross
nitrophenol
Prior art date
Application number
IT7649/65A
Other languages
English (en)
Italian (it)
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of IT961352B publication Critical patent/IT961352B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72Encapsulation
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/74Fixation, conservation, or encapsulation of flavouring agents with a synthetic polymer matrix or excipient, e.g. vinylic, acrylic polymers
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/75Fixation, conservation, or encapsulation of flavouring agents the flavouring agents being bound to a host by chemical, electrical or like forces, e.g. use of precursors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/16Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/16Cyclodextrin; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
IT7649/65A 1964-04-29 1965-04-06 Resine di inclusione e procedi mento per la loro preparazione IT961352B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH561564A CH445129A (fr) 1964-04-29 1964-04-29 Procédé pour la préparation de composés d'inclusion à poids moléculaire élevé

Publications (1)

Publication Number Publication Date
IT961352B true IT961352B (it) 1973-12-10

Family

ID=4296563

Family Applications (1)

Application Number Title Priority Date Filing Date
IT7649/65A IT961352B (it) 1964-04-29 1965-04-06 Resine di inclusione e procedi mento per la loro preparazione

Country Status (10)

Country Link
US (1) US3420788A (https=)
BE (1) BE662174A (https=)
CH (1) CH445129A (https=)
DK (1) DK132259C (https=)
ES (1) ES312034A1 (https=)
GB (1) GB1091637A (https=)
IT (1) IT961352B (https=)
NL (1) NL6505361A (https=)
NO (2) NO126377B (https=)
SE (2) SE333240B (https=)

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177419B (en) * 1978-07-13 1981-10-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing threedimensional,retentive polymers consisting of cyclodextrin and polyvinylalcohol units,capable of forming inclusion complexes in the form of bead,fibre or mainly block
EP0013688B1 (en) * 1978-12-15 1984-02-01 Kyoshin Co., Ltd. A perfumed synthetic resin product and a method of producing said product
JPS609524B2 (ja) * 1979-06-01 1985-03-11 理化学研究所 シクロデキストリンの回収法
HU184066B (en) * 1979-12-28 1984-06-28 Chinoin Gyogyszer Es Vegyeszet Plant growth regulating substance and process for preparing such compound
HU181733B (en) * 1980-08-07 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing sorbents containing cyclodextrin on cellulose base
JPS57130914A (en) * 1981-02-04 1982-08-13 Agency Of Ind Science & Technol Prolongation of activity retention
HU189534B (en) * 1981-09-09 1986-07-28 Chinoin Rt.,Hu Process for producing new tablets containing cyclodextrin polymer as desintegrator
US4448789A (en) * 1982-08-27 1984-05-15 Warner-Lambert Company Enhanced flavor-releasing agent
HU191101B (en) * 1983-02-14 1987-01-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups
JPS6081166A (ja) * 1983-10-11 1985-05-09 Fujisawa Pharmaceut Co Ltd 2−ニトロオキシメチル−6−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法
JPS60202115A (ja) * 1984-03-27 1985-10-12 Ichiro Shibauchi エポキシ樹脂用硬化剤
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
JPS61152765A (ja) * 1984-12-27 1986-07-11 Nippon Ekishiyou Kk シクロデキストリン類で包接された化合物を含有した合成樹脂製品及びその製造方法
US4769474A (en) * 1985-04-10 1988-09-06 Mitsui Toatsu Chemicals, Inc. Process for purifying tryptophane
SE452469B (sv) * 1986-06-18 1987-11-30 Pharmacia Ab Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
US4897472A (en) * 1986-11-19 1990-01-30 Oy Alko Ab Process for isolation and purification of cyclodextrins
US4808232A (en) * 1986-12-08 1989-02-28 American Maize-Products Company Separation and purification of cyclodextrins
US5273820A (en) * 1986-12-08 1993-12-28 American Maize-Products Company Separation and purification of cyclodextrins
US4898921A (en) * 1987-06-03 1990-02-06 Montclair State College Conducting polymer films, method of manufacture and applications therefor
US5637575A (en) * 1988-01-19 1997-06-10 The Trustees Of The University Of Pennsylvania Methods of inhibiting restenosis
US5760015A (en) * 1988-01-19 1998-06-02 The Trustees Of The University Of Pennsylvania Cyclodextrin compounds and methods of making and use thereof
US5658894A (en) * 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
JPH0269540A (ja) * 1988-09-05 1990-03-08 Chisso Corp 結晶性ポリオレフイン組成物
US5441944A (en) * 1989-04-23 1995-08-15 The Trustees Of The University Of Pennsylvania Substituted cyclodextrin sulfates and their uses as growth modulating agents
US5075432A (en) * 1989-08-11 1991-12-24 Edward Vanzo Spherical cyclodextrin polymer beads
IT1255981B (it) * 1991-04-30 1995-11-17 Ministero Dell Uni E Della Composizione adesiva a piu' componenti
US5446030A (en) * 1991-09-19 1995-08-29 Weisz; Paul B. Prevention of hemolysis
EP0697874A1 (en) * 1993-03-31 1996-02-28 The Trustees Of The University Of Pennsylvania Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
US5492947A (en) * 1994-06-23 1996-02-20 Aspen Research Corporation Barrier material comprising a thermoplastic and a compatible cyclodextrin derivative
US6048736A (en) * 1998-04-29 2000-04-11 Kosak; Kenneth M. Cyclodextrin polymers for carrying and releasing drugs
JP2006515640A (ja) * 2003-01-16 2006-06-01 コーネル・リサーチ・ファンデーション・インコーポレイテッド 部分的に生分解可能な温度およびpH感受性ヒドロゲル
AU2004263830B2 (en) 2003-06-13 2008-12-18 Alnylam Pharmaceuticals, Inc. Double-stranded ribonucleic acid with increased effectiveness in an organism
US20050176680A1 (en) 2003-12-11 2005-08-11 Sepracor, Inc. Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
AU2005216949B2 (en) 2004-02-24 2011-09-22 The General Hospital Corporation Catalytic radiofluorination
US7674778B2 (en) 2004-04-30 2010-03-09 Alnylam Pharmaceuticals Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine
ATE548359T1 (de) 2004-06-17 2012-03-15 Infinity Discovery Inc Verbindungen und verfahren zur inhibierung der wechselwirkung von bcl-proteinen mit bindungspartnern
NZ560962A (en) * 2005-02-18 2011-12-22 Surface Logix Inc Methods of making pharmacokinetically improved compounds using sarcosine functional residues or groups and pharmaceutical compositions comprising said compounds
CA2598271A1 (en) * 2005-02-18 2006-08-24 Surface Logix, Inc. Pharmacokinetically improved compounds
ES2310948B2 (es) * 2005-02-25 2009-09-16 Universidade De Santiago De Compostela Procedimiento de obtencion de hidrogeles de ciclodextrinas con glicidileteres, las composiciones obtenidas y sus aplicaciones.
US8669236B2 (en) * 2005-05-12 2014-03-11 The General Hospital Corporation Biotinylated compositions
KR100791978B1 (ko) * 2005-06-21 2008-01-04 곽해수 콜레스테롤 제거용 베타-싸이클로덱스트린의 가교화 및그의 재생방법
KR101403887B1 (ko) 2006-08-03 2014-06-20 트러스티즈 오브 터프츠 칼리지 홍조화를 유발하지 않는 니아신 유사체, 및 이의 사용 방법
KR100785913B1 (ko) * 2006-11-29 2007-12-17 한국과학기술연구원 경화된 β-사이클로덱스트린 중합체 분말과 그의 제조방법
WO2009013770A1 (en) * 2007-07-26 2009-01-29 Humanitas Mirasole S.P.A. Derivatised polysaccharide material for the transdermal administration of drugs
US20090060860A1 (en) * 2007-08-31 2009-03-05 Eva Almenar Beta-cyclodextrins as nucleating agents for poly(lactic acid)
CN112574988A (zh) 2008-10-24 2021-03-30 萨雷普塔治疗公司 用于dmd的多外显子跳跃组合物
AU2010319314C1 (en) 2009-11-13 2016-09-01 Sarepta Therapeutics, Inc. Antisense antiviral compound and method for treating influenza viral infection
EP2545173A2 (en) 2010-03-12 2013-01-16 Sarepta Therapeutics, Inc. Antisense modulation of nuclear hormone receptors
ES2816898T3 (es) 2010-05-13 2021-04-06 Sarepta Therapeutics Inc Compuestos que modulan la actividad de señalización de las interleucinas 17 y 23
WO2011163612A1 (en) 2010-06-24 2011-12-29 Trustees Of Tufts College Niacin mimetics, and methods of use thereof
JP5925771B2 (ja) 2010-06-24 2016-05-25 トラスティーズ オブ タフツ カレッジ ナイアシン模倣体、およびその使用方法
US10463687B2 (en) 2011-01-20 2019-11-05 Cornell University Treatments for retinal disorders
EP2732035A2 (en) 2011-07-15 2014-05-21 Sarepta Therapeutics, Inc. Methods and compositions for manipulating translation of protein isoforms from alternative initiation start sites
EP2788487B1 (en) 2011-12-08 2018-04-04 Sarepta Therapeutics, Inc. Oligonucleotide analogues targeting human lmna
JP2015503518A (ja) 2011-12-23 2015-02-02 ノバルティス アーゲー Bcl2と結合相手の相互作用を阻害するための化合物
BR112014015442A8 (pt) 2011-12-23 2017-07-04 Novartis Ag compostos e composições para inibir a interação de bcl2 com parceiros de ligação
EP2794592A1 (en) 2011-12-23 2014-10-29 Novartis AG Compounds for inhibiting the interaction of bcl2 with binding partners
EP2794588A1 (en) 2011-12-23 2014-10-29 Novartis AG Compounds for inhibiting the interaction of bcl2 with binding partners
MX2014007732A (es) 2011-12-23 2015-01-12 Novartis Ag Compuestos para inhibir la interaccion de bcl2 con los mismos componentes de enlace.
PT2861579T (pt) 2012-05-15 2018-04-27 Novartis Ag Derivados de benzamida para inibir a atividade de abl1, abl2 e bcr-abl
KR20150008406A (ko) 2012-05-15 2015-01-22 노파르티스 아게 Abl1, abl2 및 bcr-abl1의 활성을 억제하기 위한 벤즈아미드 유도체
ES2670667T3 (es) 2012-05-15 2018-05-31 Novartis Ag Derivados de benzamida para inhibir la actividad de ABL1, ABL2 y BCR-ABL1
WO2013171641A1 (en) 2012-05-15 2013-11-21 Novartis Ag Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1
EP2890788A1 (en) 2012-08-31 2015-07-08 The General Hospital Corporation Biotin complexes for treatment and diagnosis of alzheimer's disease
FR2999916B1 (fr) 2012-12-20 2015-01-30 Oreal Composition permettant la liberation d'agent benefique comprenant un polycondensat de cyclodextrine insoluble dans l'eau et au moins un agent benefique
FR3000080B1 (fr) 2012-12-20 2015-01-30 Oreal Polycondensat de cyclodextrine insoluble dans l'eau ; utilisations comme agent de capture
CA2894899A1 (en) 2012-12-20 2014-06-26 Sarepta Therapeutics, Inc. Improved exon skipping compositions for treating muscular dystrophy
BR112015018882B1 (pt) 2013-02-19 2021-09-14 Novartis Ag Derivados de benzotiofeno e composições dos mesmos como degradadores de receptor de estrogênio seletivo
RS58529B1 (sr) 2013-03-14 2019-04-30 Sarepta Therapeutics Inc Sastavi koji preskaču egzon za tretiranje mišićne distrofije
NZ731587A (en) 2013-03-14 2021-07-30 Sarepta Therapeutics Inc Exon skipping compositions for treating muscular dystrophy
CA2906812A1 (en) 2013-03-15 2014-09-18 Sarepta Therapeutics, Inc. Improved compositions for treating muscular dystrophy
WO2015022663A1 (en) 2013-08-14 2015-02-19 Novartis Ag Compounds and compositions as inhibitors of mek
WO2015022664A1 (en) 2013-08-14 2015-02-19 Novartis Ag Compounds and compositions as inhibitors of mek
US9227969B2 (en) 2013-08-14 2016-01-05 Novartis Ag Compounds and compositions as inhibitors of MEK
WO2015092634A1 (en) 2013-12-16 2015-06-25 Novartis Ag 1,2,3,4-tetrahydroisoquinoline compounds and compositions as selective estrogen receptor antagonists and degraders
JO3517B1 (ar) 2014-01-17 2020-07-05 Novartis Ag ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2
CN105899493B (zh) 2014-01-17 2019-03-29 诺华股份有限公司 用于抑制shp2活性的1-(三嗪-3-基/哒嗪-3-基)-哌(-嗪)啶衍生物及其组合物
JP6523303B2 (ja) 2014-01-17 2019-05-29 ノバルティス アーゲー Shp2の活性を阻害するための1−ピリダジン/トリアジン−3−イル−ピペラジン/ピペリジン/ピロリジン誘導体およびその組成物
CA3193201A1 (en) 2014-05-06 2015-11-12 Anthony G. Visco Methods of treating or preventing preterm labor
WO2016160310A1 (en) * 2015-04-01 2016-10-06 The Chemours Company Fc, Llc Stabilized composition for combined odor control and enhanced dewatering
CN112625028B (zh) 2015-06-19 2024-10-29 诺华股份有限公司 用于抑制shp2活性的化合物和组合物
ES2741746T3 (es) 2015-06-19 2020-02-12 Novartis Ag Compuestos y composiciones para inhibir la actividad de SHP2
ES2824576T3 (es) 2015-06-19 2021-05-12 Novartis Ag Compuestos y composiciones para inhibir la actividad de SHP2
EA201890811A1 (ru) 2015-09-30 2018-09-28 Сарепта Терапьютикс, Инк. Способы лечения мышечной дистрофии
CN109477109B (zh) 2016-04-29 2022-09-23 萨勒普塔医疗公司 靶向人lmna的寡核苷酸类似物
MX383856B (es) 2016-06-14 2025-03-14 Novartis Ag Compuestos y composiciones para inhibir la actividad de shp2.
TW201811807A (zh) 2016-06-30 2018-04-01 美商薩羅塔治療公司 用於肌肉萎縮症之外顯子跳躍寡聚物
IL297528A (en) 2016-12-19 2022-12-01 Sarepta Therapeutics Inc Exon-skipping oligomer conjugates for muscular dystrophy
SMT202200366T1 (it) 2016-12-19 2022-11-18 Sarepta Therapeutics Inc Coniugati di oligomeri per salto di esone per distrofia muscolare
SI3554554T1 (sl) 2016-12-19 2023-02-28 Sarepta Therapeutics, Inc. Oligomerni konjugati, ki preskakujejo ekson za mišično distrofijo
CN110536694A (zh) 2017-04-20 2019-12-03 Atyr 医药公司 用于治疗肺部炎症的组合物和方法
EA201991450A1 (ru) 2017-09-22 2019-12-30 Сарепта Терапьютикс, Инк. Конъюгаты олигомеров для пропуска экзона при мышечной дистрофии
JP2020536058A (ja) 2017-09-28 2020-12-10 サレプタ セラピューティクス, インコーポレイテッド 筋ジストロフィーを処置するための併用療法
WO2019067975A1 (en) 2017-09-28 2019-04-04 Sarepta Therapeutics, Inc. POLYTHERAPIES FOR TREATING MUSCLE DYSTROPHY
WO2019067979A1 (en) 2017-09-28 2019-04-04 Sarepta Therapeutics, Inc. POLYTHERAPIES FOR TREATING MUSCLE DYSTROPHY
US10758629B2 (en) 2018-05-29 2020-09-01 Sarepta Therapeutics, Inc. Exon skipping oligomer conjugates for muscular dystrophy
EP3806868A4 (en) 2018-06-13 2022-06-22 Sarepta Therapeutics, Inc. EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY
CN108435148A (zh) * 2018-06-21 2018-08-24 黄益良 一种环糊精改性聚丙烯酰胺污水处理剂及其制备方法
CA3106563A1 (en) 2018-07-26 2020-01-30 Atyr Pharma, Inc. Compositions and methods for treating nrp2-associated diseases
TW202020153A (zh) 2018-07-27 2020-06-01 美商薩羅塔治療公司 用於肌肉萎縮症之外顯子跳躍寡聚物
MX2021006737A (es) 2018-12-13 2021-09-23 Sarepta Therapeutics Inc Conjugados de oligómeros de salto de exones para distrofia muscular.
JP7607935B2 (ja) 2019-01-03 2025-01-06 サイクラリティ・セラピューティクス・インコーポレイテッド シクロデキストリン二量体、それらの組成物、及びそれらの使用
CN109663578B (zh) * 2019-02-22 2022-02-25 安徽大学 一种对刚果红超高吸附能力的混合卤化物(MV)[BiI3Cl2]的制备方法及其产品
CN109806849A (zh) * 2019-03-25 2019-05-28 东华大学 一种环糊精纳米空心小球及其制备方法
WO2020198268A1 (en) 2019-03-28 2020-10-01 Sarepta Therapeutics, Inc. Methods for treating muscular dystrophy with casimersen
EP3955966A1 (en) 2019-04-18 2022-02-23 Sarepta Therapeutics, Inc. Compositions for treating muscular dystrophy
EP3987029A1 (en) 2019-06-19 2022-04-27 Sarepta Therapeutics, Inc. Methods for treating muscular dystrophy
WO2021101606A1 (en) * 2019-11-18 2021-05-27 Pmidg, Llc Compositions for sunscreen compounds and methods thereof
CN113019344A (zh) * 2021-03-16 2021-06-25 大连理工大学 一种具有选择性吸附的球形零价铁-环糊精复合材料的制备方法及应用
CN113372674B (zh) * 2021-08-13 2021-10-19 山东三义集团股份有限公司 一种氯化聚乙烯用高速挤出加工改性助剂的制备方法
JP2025509438A (ja) 2022-03-17 2025-04-11 サレプタ セラピューティクス, インコーポレイテッド ホスホロジアミデートモルホリノオリゴマーコンジュゲート
EP4593855A1 (en) 2022-09-28 2025-08-06 Altos Labs, Inc. Expression of regeneration factors in aged/senescent cells
AU2023420130A1 (en) 2022-12-30 2025-08-14 Cornell University Acid cyclodextrins for the treatment of lipofuscin buildups and ocular diseases
CN120441878B (zh) * 2025-07-09 2025-10-17 成都飞机工业(集团)有限责任公司 一种去除无氰电镀镉溶液中金属杂质的聚合物树脂及其制备方法与使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2801184A (en) * 1952-01-18 1957-07-30 Miyamoto Katsuhei Colloidal suspension of amylose and alpha-amylodextrin
NL98574C (https=) * 1958-01-29
US2977356A (en) * 1958-05-27 1961-03-28 Anheuser Busch Process for preparing cross-linked starch ethers in granule form
US2973243A (en) * 1958-08-26 1961-02-28 Kudera Dieter Process for producing threads, foils, tubes and the like from amylose and/or starch carbohydrates containing amylose
NL126243C (https=) * 1959-06-12
US2989521A (en) * 1959-06-30 1961-06-20 Frederic R Senti Method of cross-linking and oxidizing starch
US3282870A (en) * 1963-11-29 1966-11-01 Dow Chemical Co Starch and polycarboxamide reaction products

Also Published As

Publication number Publication date
DE1493047B2 (de) 1973-01-11
ES312034A1 (es) 1966-02-01
DK132259B (da) 1975-11-17
GB1091637A (en) 1967-11-22
BE662174A (https=) 1965-10-07
DE1493047A1 (de) 1969-01-02
US3420788A (en) 1969-01-07
NO127814B (https=) 1973-08-20
SE365234B (https=) 1974-03-18
NO126377B (https=) 1973-01-29
NL6505361A (https=) 1965-11-01
CH445129A (fr) 1967-10-15
SE333240B (sv) 1971-03-08
DK132259C (da) 1976-05-03

Similar Documents

Publication Publication Date Title
IT961352B (it) Resine di inclusione e procedi mento per la loro preparazione
Björkman Isolation of lignin from finely divided wood with neutral solvents
Umemura et al. Application of citric acid as natural adhesive for wood
Baiardo et al. Surface chemical modification of natural cellulose fibers
Pei et al. Tannin‐immobilized cellulose microspheres as effective adsorbents for removing cationic dye (Methylene Blue) from aqueous solution
KR100485231B1 (ko) 비닐페놀형폴리머로부터의금속제거방법
Anderson et al. Composition of gum exudates from Anacardium occidentale
CN105107485A (zh) 一种固化单宁吸附树脂的制备方法
CN104226267A (zh) 磁性纤维素/氧化石墨烯复合吸附剂及其制备方法
CN102989400A (zh) 一种琼脂糖4b微球的交联方法
CN109333719B (zh) 一种糠醇树脂木材改性剂及其制备方法与应用
SE7610611L (sv) Forfarande for framstellning av svellbara cellulosaetrar
Gomes et al. Surface Molecularly Imprinted Cellulose‐Synthetic Hybrid Particles Prepared via ATRP for Enrichment of Flavonoids in Olive Leaf
GB967772A (en) Improvements relating to polyethylene imine anion exchange resins
GB1242735A (en) Polysaccharide derivatives
WO2015129622A1 (ja) 液体クロマトグラフィー用充填剤及び液体クロマトグラフィー用カラム
Dee et al. N-Methylimidazole as a catalyst for acetylation of hydroxyl terminated polymers
GB1001364A (en) Process of manufacturing epoxide resins
Kiso et al. Retention characteristics of aliphatic compounds on cellulose acetates as a stationary phase with an aqueous mobile phase
GB918050A (en) Improvements in and relating to anchoring surface coatings to cellulosic surfaces
CN116874686A (zh) 一种离子交换树脂及其制备方法
GB992201A (en) Method for the extraction of sulphated polysaccharides
Skvortsov Radiation degradation of lignin
Xue et al. Preparation and characterization of formaldehyde crosslinked chitosan
GB1002269A (en) Process for the manufacture of methylal